Clinical Edge Journal Scan

Gastric cancer: Perioperative outcomes with laparoscopic vs open surger


 

Key clinical point: Compared with the open gastrectomy, laparoscopic gastrectomy is associated with less intraoperative blood loss, shorter hospitalization time, and early postoperative exhaust in patients with gastric cancer.

Major finding: Patients in the laparoscopic vs open gastrectomy group had less intraoperative bleeding (standardized mean difference [SMD] −1.11; P = .0006), early postoperative exhaust (SMD −0.45; P = .0004), first postoperative feeding (SMD −0.45; P = .0004), and shorter postoperative hospital stay (SMD­ −0.97; P = .008), but had a longer operation time (SMD­ 0.65; P < .00001). There was no significant difference in the number of lymph nodes dissected ( P = .45) and the incidence of complications after 30 days of surgery ( P = .23) between the 2 groups.

Study details: These results are from a meta-analysis 11 studies including 1027 patients with gastric cancer who underwent laparoscopic or open gastrectomy.

Disclosures: This study was supported by Key Clinical Subject construction Program of Chongqing Medical University, China. The authors declared no conflicts of interest.

Source: Huang K et al. Effects of laparoscopic versus open surgery for advanced gastric cancer after neoadjuvant chemotherapy: A meta-analysis. J Healthc Eng. 2022;3255403 (Jun 18). Doi: 10.1155/2022/3255403

Recommended Reading

Beta adrenergic blockade improves the prognosis of patients with CRC
MDedge Hematology and Oncology
Advanced gastric cancer: Efficacy of anti-PD-1 antibodies plus multikinase inhibitors unaffected by liver metastasis
MDedge Hematology and Oncology
Chemoradiotherapy improves survival in resectable gastric cancer
MDedge Hematology and Oncology
Better survival in patients with MSI-high vs MSS gastric cancer despite worse chemotherapy response
MDedge Hematology and Oncology
Hyperglycemia and low BMI increase the risk for gastric cancer
MDedge Hematology and Oncology
Gastric cancer: Neoadjuvant chemotherapy improves outcomes
MDedge Hematology and Oncology
Cisplatin not inferior to oxaliplatin for systemic treatment of resectable GC
MDedge Hematology and Oncology
Dietary iron protects against gastric cancer
MDedge Hematology and Oncology
Mediterranean diet protects against gastric cancer
MDedge Hematology and Oncology
Advanced gastric cancer: Surgical palliation worsens survival outcomes
MDedge Hematology and Oncology